Scandinavian ChemoTech’s Chief Medical Officer, Suhail Mufti, delivers clinical update
This is the second clinical update following the introduction of TSE (Tumour Specific Electroporation™) in the curative treatment line of Head and Neck (H&N) cancer at AIIMS Jodhpur. In this update, CMO Suhail Mufti provides insights into the long-term clinical study objectives and key milestones. Clinical Trial Progress in University Hospital in Jodhpur India, non-sponsored trials: 1. Patient enrolment began as scheduled, following the Ethics Committee approval of the revised clinical study protocol, as publicly announced on November 29, 2023. 2. The latest protocol